Elanco

Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors

Retrieved on: 
Monday, April 1, 2024
Productivity, Oversight Committee, Elanco, Innovation, Growth, Abbott Laboratories, Trupanion, Strategic planning, Idexx Laboratories, Laboratory, ELAN, Fortification, Management

GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.

Key Points: 
  • New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee
    GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.
  • Ms. Turner brings significant global experience in both the animal health and broader healthcare industries.
  • Mr. Wallace is a well-respected animal health leader with more than 30 years of executive experience at companies such as Fort Dodge Animal Health, Trupanion and Ceva.
  • "We are pleased to welcome Kathy and Craig, both accomplished animal health industry executives, to the Elanco Board," said Jeff Simmons, President and CEO of Elanco Animal Health.

Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, February 26, 2024
Shift, ERP, Schering-Plough, Selection, Research, Poultry, Sheep, Sale, European, Elanco, Farm Animal, GAAP, Pressure, Video game

Other expense was $34 million in the fourth quarter of 2023 on a reported basis, compared to $21 million in the fourth quarter of 2022.

Key Points: 
  • Other expense was $34 million in the fourth quarter of 2023 on a reported basis, compared to $21 million in the fourth quarter of 2022.
  • The reported effective tax rate was negative 11.1% in the fourth quarter of 2023 compared to 39.2% in the fourth quarter of 2022.
  • Adjusted EBITDA was $165 million in the fourth quarter of 2023, a decrease of 4% compared to the fourth quarter of 2022.
  • Cash provided by operations was $157 million in the fourth quarter of 2023 compared to $13 million in the fourth quarter of 2022.

Animal Wound Care Market Worth $2.0 Billion | MarketsandMarkets™.

Retrieved on: 
Thursday, February 8, 2024
Foam, 3M, GCC, Elanco, Wound healing, Prevalence, Livestock, Pulse, Growth, Investment, Injury, Health, Nature, Risk, Animal, Infection, Pithing, Telehealth, Environment, Veterinary medicine, Medtronic, Research, Bandage, Market development, Pet industry

The animal wound care market is further segmented based on the product, animal type, end-user, and region.

Key Points: 
  • The animal wound care market is further segmented based on the product, animal type, end-user, and region.
  • The animal wound care market for foam dressing is experiencing significant growth due to several key factors that highlight the efficacy and versatility of foam-based wound care solutions.
  • Animal Wound Care Market Dynamics:
    Key Market Players of Animal Wound Care Industry:
    The global animal wound care market is consolidated in nature, with the top players, namely, Elanco Animal Health (US), 3M Company (US), Medtronic PLC (Ireland), B. Braun Melsungen AG (Germany), Virbac (France), accounting for a larger share of the market.
  • A breakdown of the primary participants (supply-side) for the animal wound care market referred to for this report is provided below:
    Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=253831778
    Animal Wound Care Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall animal wound care market and the subsegments.

Animal Wound Care Market Worth $2.0 Billion | MarketsandMarkets™.

Retrieved on: 
Thursday, February 8, 2024
Foam, 3M, GCC, Elanco, Wound healing, Prevalence, Livestock, Pulse, Growth, Investment, Injury, Health, Nature, Risk, Animal, Infection, Pithing, Telehealth, Environment, Veterinary medicine, Medtronic, Research, Bandage, Market development, Pet industry

The animal wound care market is further segmented based on the product, animal type, end-user, and region.

Key Points: 
  • The animal wound care market is further segmented based on the product, animal type, end-user, and region.
  • The animal wound care market for foam dressing is experiencing significant growth due to several key factors that highlight the efficacy and versatility of foam-based wound care solutions.
  • Animal Wound Care Market Dynamics:
    Key Market Players of Animal Wound Care Industry:
    The global animal wound care market is consolidated in nature, with the top players, namely, Elanco Animal Health (US), 3M Company (US), Medtronic PLC (Ireland), B. Braun Melsungen AG (Germany), Virbac (France), accounting for a larger share of the market.
  • A breakdown of the primary participants (supply-side) for the animal wound care market referred to for this report is provided below:
    Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=253831778
    Animal Wound Care Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall animal wound care market and the subsegments.

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement

Retrieved on: 
Thursday, February 8, 2024
Elanco, ELAN

GREENFIELD, Ind., Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024.

Key Points: 
  • GREENFIELD, Ind., Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024.
  • Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
  • The conference call will begin at 8:00 a.m. eastern time.
  • Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website on our events and presentations page.

Merck Animal Health to Acquire Elanco’s Aqua Business

Retrieved on: 
Monday, February 5, 2024
Biotechnology, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Fitness & Nutrition, Science, Veterinary, Clinical Trials, MSD, Schering-Plough, Elanco, PIT, Vaki, ELAN, MRK, Goldman Sachs, Covington & Burling, Water, Vaccine, Acquisition, Merck, Merck & Co., LLP, Aquaculture

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile.

Key Points: 
  • Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile.
  • “We are excited for the acquisition of Elanco’s aqua products, solutions as well as the capabilities and expertise the team brings to our business,” said Rick DeLuca, president, Merck Animal Health.
  • The addition of this innovative portfolio of cold water and warm water aqua products across vaccines, anti-parasitic treatments, water supplements and nutrition, will establish Merck Animal Health as a leader in aqua.”
    Elanco Animal Health President and CEO Jeff Simmons said, “Following a robust process over the last year, Merck Animal Health emerged as the right strategic buyer for the aquaculture business.
  • In March 2019, Merck Animal Health acquired Scan Aqua AS, a fish health and fish welfare company based in Norway, focused on key aqua products.

2024 Feather in Her Cap and High Flyer Award Winners Named for Outstanding Achievements in Animal Health Industry

Retrieved on: 
Tuesday, January 16, 2024
Philanthropy, Health, Consumer, Women, Foundation, Veterinary, Animal Health, Woman, Osteoarthritis, Therapy, Frunevetmab, Multimedia, Female, Intellectual disability, University, Engagement, Mentorship, Dog, Pharmaceutics, Elanco, Veteran, Cat, DVM, Boehringer Ingelheim, ELAN, Doctor of Philosophy, Veterinary medicine, Highflyer, Feather, Marketing, Formulation, Inclusion, Education, Management

The Feather in Her Cap Association, Inc. and 300 industry leaders honored 11 women for their outstanding career achievements in Animal Health at the seventh annual Feather in Her Cap awards ceremony.

Key Points: 
  • The Feather in Her Cap Association, Inc. and 300 industry leaders honored 11 women for their outstanding career achievements in Animal Health at the seventh annual Feather in Her Cap awards ceremony.
  • Andrea J. Gonzales Ph.D., vice president of Global Companion Animal Therapeutics at Zoetis, Inc., (NYSE: ZTS) was awarded the 2024 Feather in Her Cap award and Katharina Bohnenblust Ph.D., senior director, head of Formulation Development at Elanco Animal Health (NYSE: ELAN) was this year’s recipient of the 2024 High Flyer award.
  • Each year, the Feather in Her Cap award winner chooses an animal-related non-profit organization to receive a $5,000 donation.
  • The nomination process will reopen in Q3 of 2024 to celebrate more outstanding women in Animal Health in 2025.

Europe Pet Supplements Market Report 2023: Focused Insights, Market Dynamics, Competitive Landscape, Trends and Forecasts 2022-2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 16, 2023
Retail, Health, Consumer, Specialty, Pets, Vitamins, Supplements, Veterinary, Sale, Diet, Capsule, Hip, Pet, Compana, Cat, Immune system, Mineral, Incidence, Tablet, Powder, Dechra Pharmaceuticals, Animal, Nutrient, Vitamin, Veterinarian, Growth, Dog, Dietary supplement, Pet industry, Elanco, Nestlé

The "Europe Pet Supplements Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Pet Supplements Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • This report provides market size and forecast data for the European pet supplements market, including revenue generated from the sale of pet supplements.
  • It offers a comprehensive overview of the current market scenario in Europe, including market size, anticipated market forecasts, relevant market segmentations, and industry trends for the period 2023-2028.
  • The study examines the current dynamics of the pet supplements market in Europe, covering growth enablers, restraints, and trends.

Animal Parasiticides Market is Anticipated to Reach USD 15.6 billion, at a CAGR of 5.7% CAGR by 2031 - Report by Transparency Market Research Inc.

Retrieved on: 
Tuesday, December 12, 2023
Merck & Co., Research, Safety, Pig, Urbanization, Boehringer Ingelheim, Bayer, Virbac, Research report, Animal, Parasitism, Merck, Zoonosis, Probiotic, Nanotechnology, Growth, Knowledge, Livestock, Poultry, Cattle, Pet industry, Agriculture, Fine chemical, Elanco

WILMINGTON, Del., Dec. 12, 2023 /PRNewswire/ -- The global animal parasiticides market is estimated to flourish at a CAGR of 5.7% from 2023 to 2031. According to Transparency Market Research, sales of animal parasiticides are slated to total US$ 15.6 billion by the end of the aforementioned period of assessment.

Key Points: 
  • Growing urbanization, rising disposable income, and improved awareness about animal health amplify the demand for effective parasiticides.
  • Spot-on treatments and oral tablets dominate the animal parasiticides market, offering efficient and convenient solutions for parasite control in animals.
  • Food-producing animals, particularly cattle, poultry, and swine, lead the animal parasiticides market due to their extensive agricultural significance.
  • North America leads the animal parasiticides market due to advanced research, stringent regulations, and robust veterinary healthcare infrastructure.

Animal Parasiticides Market is Anticipated to Reach USD 15.6 billion, at a CAGR of 5.7% CAGR by 2031 - Report by Transparency Market Research Inc.

Retrieved on: 
Tuesday, December 12, 2023
Merck & Co., Research, Safety, Pig, Urbanization, Boehringer Ingelheim, Bayer, Virbac, Research report, Animal, Parasitism, Merck, Zoonosis, Probiotic, Nanotechnology, Growth, Knowledge, Livestock, Poultry, Cattle, Pet industry, Agriculture, Fine chemical, Elanco

WILMINGTON, Del., Dec. 12, 2023 /PRNewswire/ -- The global animal parasiticides market is estimated to flourish at a CAGR of 5.7% from 2023 to 2031. According to Transparency Market Research, sales of animal parasiticides are slated to total US$ 15.6 billion by the end of the aforementioned period of assessment.

Key Points: 
  • Growing urbanization, rising disposable income, and improved awareness about animal health amplify the demand for effective parasiticides.
  • Spot-on treatments and oral tablets dominate the animal parasiticides market, offering efficient and convenient solutions for parasite control in animals.
  • Food-producing animals, particularly cattle, poultry, and swine, lead the animal parasiticides market due to their extensive agricultural significance.
  • North America leads the animal parasiticides market due to advanced research, stringent regulations, and robust veterinary healthcare infrastructure.